Siskin, M., Saha, J., Antonarakis, E. S., Leal, A., Parry, S., Tsai, J., Wise, D. R. (2025). Real world outcomes for patients with metastatic castration resistant prostate cancer (mCRPC) and
            <i>AR</i>
            T878A alterations treated with enzalutamide.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5053